Related Experiment Video
Updated: Jan 7, 2026

08:00
Decoding Natural Behavior from Neuroethological Embedding
Published on: October 3, 2025
548
ViVo: A Temporal Modeling Framework That Boosts Statistical Power and Minimizes Animal Usage
Guillermo Canudo-Barreras1, Eduardo Romanos2, Raquel P Herrera1
1Instituto de Síntesis Química y Catálisis Homogénea (ISQCH) CSIC-Universidad de Zaragoza, C/Pedro Cerbuna 12, Zaragoza 50009, Spain.
Journal of Medicinal Chemistry
|December 29, 2025
Summary
This study introduces a new exponential framework to accurately estimate tumor growth rates and reveal hidden treatment effects in preclinical studies. The ViVo platform offers accessible analysis of in vivo tumor kinetics and therapeutic efficacy.
Area of Science:
- Oncology
- Pharmacology
- Biostatistics
Background:
- Preclinical tumor studies face challenges with high variability and small sample sizes, limiting statistical power and obscuring treatment effects.
- Existing methods often struggle to detect subtle therapeutic impacts due to these limitations.
Purpose of the Study:
- To develop a robust framework for analyzing preclinical tumor growth kinetics and treatment efficacy.
- To improve statistical power and reveal treatment effects masked by variability in small-sample studies.
Main Methods:
- An exponential framework was developed to estimate tumor growth rates (r) independent of initial tumor burden.
- Tumor Growth Rate (TGR) matrices were introduced to map treatment effects across defined time windows.
- The framework was validated using public xenograft data and four additional mouse models.
Main Results:
- Exponential fits demonstrated high agreement with raw tumor growth data (median R² = 0.937).
- The proposed approach consistently outperformed conventional endpoint and daily nonparametric analyses in detecting treatment effects, especially with small sample sizes (n=3-7).
- The framework successfully predicted tumor weights for early-euthanized animals, enhancing statistical consistency and supporting the 3Rs principles.
Conclusions:
- The novel exponential framework provides a powerful and statistically robust method for analyzing preclinical tumor growth and therapeutic efficacy.
- The open-source ViVo web platform facilitates accessible and standardized analysis of in vivo tumor kinetics, promoting wider adoption in cancer research.

